India to United States: Vati Export Trade Route
India has recorded 373 verified shipments of Vati exported to United States, representing a combined trade value of $8.3M USD. This corridor is served by 32 active Indian exporters, with an average shipment value of $22.3K USD. The leading Indian exporter is EUGIA PHARMA SPECIALITIES LIMITED, which accounts for 45% of total export value with 26 shipments worth $3.7M USD. On the buying side, AUROBINDO PHARMA USA INC is the largest importer in United States with $3.1M USD in purchases. The top 3 suppliers — EUGIA PHARMA SPECIALITIES LIMITED, MANKIND PHARMA LIMITED, MANKIND PHARMA LTD — together control 91% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to United States Vati corridor is one of India's established pharmaceutical export routes, with 373 shipments documented worth a combined $8.3M USD. The route is dominated by EUGIA PHARMA SPECIALITIES LIMITED, which alone accounts for roughly 45% of all export value, reflecting the consolidated nature of India's vati manufacturing sector.
Across 32 active suppliers, the average shipment value stands at $22.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with vati's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 29.2%, placing it at rank #14 among India's top vati export destinations globally.
On the import side, key buyers of Indian vati in United States include AUROBINDO PHARMA USA INC, LIFESTAR PHARMA LLC, AUROLOGISTICS LLC, (AUROBINDO PHARM and 56 others. AUROBINDO PHARMA USA INC is the single largest importer with 20 shipments valued at $3.1M USD.
Route Characteristics
- Average transit22 days
- Peak seasonQ3
- Primary modeSea freight
- Top portDELHI AIR
Market Position
- Global rank#14
- Annual growth+29.2%
- Demand growth+26.2%
- Regulatory ease76/100
Top 10 Indian Vati Exporters to United States
Showing top 10 of 32 Indian suppliers exporting Vati to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EUGIA PHARMA SPECIALITIES LIMITED Avg $142.8K per shipment | 26 | $3.7M | 44.7% |
| 2 | MANKIND PHARMA LIMITED Avg $26.5K per shipment | 125 | $3.3M | 39.9% |
| 3 | MANKIND PHARMA LTD Avg $43.7K per shipment | 12 | $524.7K | 6.3% |
| 4 | STERISCIENCE SPECIALTIES PRIVATE LIMITED Avg $20.5K per shipment | 18 | $369.7K | 4.5% |
| 5 | MICRO LABS LIMITED Avg $151.3K per shipment | 2 | $302.7K | 3.6% |
| 6 | INDIAN GLOBALSTORE Avg $364 per shipment | 39 | $14.2K | 0.2% |
| 7 | ATLAS ENTERPRISES Avg $756 per shipment | 15 | $11.3K | 0.1% |
| 8 | GLOBAL SALES & SERVICES Avg $674 per shipment | 13 | $8.8K | 0.1% |
| 9 | MONKFISH Avg $1.5K per shipment | 5 | $7.4K | 0.1% |
| 10 | GLOBAL SALES SERVICES Avg $399 per shipment | 14 | $5.6K | 0.1% |
This table shows the top 10 of 32 Indian companies exporting vati to United States, ranked by total trade value. The listed exporters are: EUGIA PHARMA SPECIALITIES LIMITED, MANKIND PHARMA LIMITED, MANKIND PHARMA LTD, STERISCIENCE SPECIALTIES PRIVATE LIMITED, MICRO LABS LIMITED, INDIAN GLOBALSTORE, ATLAS ENTERPRISES, GLOBAL SALES & SERVICES, MONKFISH, GLOBAL SALES SERVICES. EUGIA PHARMA SPECIALITIES LIMITED is the dominant supplier with 26 shipments worth $3.7M USD, giving it a 45% market share. The top 3 suppliers together account for 91% of the total trade value on this route.
Showing top 10 of 32 total Indian exporters on the India to United States Vati export route.
Top 10 Vati Importers in United States
Showing top 10 of 59 known buyers in United States receiving Vati shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian vati in United States include AUROBINDO PHARMA USA INC, LIFESTAR PHARMA LLC, AUROLOGISTICS LLC, (AUROBINDO PHARM, NORTHSTAR DISTRIBUTION CENTER 8912,, RXCROSSROADS 3PL LLC, among 59 total buyers. The largest importer is AUROBINDO PHARMA USA INC, accounting for $3.1M USD across 20 shipments — representing 38% of all vati imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AUROBINDO PHARMA USA INC | 20 | $3.1M | 37.9% |
| 2 | LIFESTAR PHARMA LLC | 105 | $2.6M | 31.7% |
| 3 | AUROLOGISTICS LLC, (AUROBINDO PHARM | 6 | $567.1K | 6.8% |
| 4 | NORTHSTAR DISTRIBUTION CENTER 8912, | 14 | $467.3K | 5.6% |
| 5 | RXCROSSROADS 3PL LLC | 18 | $369.7K | 4.5% |
| 6 | EVERSANA LIFE SCIENCE SERVICES, LLC | 2 | $302.7K | 3.6% |
| 7 | LIFESTAR PHARMA LLC C/O | 4 | $268.2K | 3.2% |
| 8 | NORTHSTAR DISTRIBUTION CENTER 8912 | 9 | $218.8K | 2.6% |
| 9 | LIFESTAR PHARMA LLCC | 4 | $209.3K | 2.5% |
| 10 | LIFESTAR PHARMA LLCC/O RXCROSSROADS | 1 | $39.8K | 0.5% |
Showing top 10 of 59 Vati importers in United States on this route.
Top 10 Vati Formulations Imported by United States
Showing top 10 of 299 product formulations shipped on the India to United States Vati route, ranked by trade value
United States imports a wide range of vati formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION 2% / 0.5% PRESERVATIVE FREE60 S PACKQTY:4932 PACKS — accounts for $306.5K USD across 2 shipments. There are 299 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION 2% / 0.5% PRESERVATIVE FREE60 S PACKQTY:4932 PACKS | 2 | $306.5K | 3.7% |
| 2 | TIMOLOL MALEATE OPHTHALMIC SOLUTION USP(0.5% W/V AS TIMOLOL) ( (PRESERVATIVE FREE) ) ( 60X0.3ML ) ( QTY- 11820.000) | 1 | $210.1K | 2.5% |
| 3 | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION 2%/0.5% PRESERVATIVE FREE(60 S PACK)(QTY: 5254 PACKS) | 1 | $163.7K | 2.0% |
| 4 | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION 2%/0.5% PRESERVATIVE FREE(60 S PACK)(QTY: 5220 PACKS) | 1 | $162.6K | 2.0% |
| 5 | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION 2%/ 0.5% PRESERVATIVE FREE60 S PACKQTY: 5224 PACKS | 1 | $162.3K | 2.0% |
| 6 | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION 2%/ 0.5% PRESERVATIVE FREE60 S PACKQTY: 5217 PACKS | 1 | $162.1K | 2.0% |
| 7 | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION 2%/0.5% PRESERVATIVE FREE(60 S PACK)(QTY: 5170 PACKS) | 1 | $161.0K | 1.9% |
| 8 | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION 2%/0.5% PRESERVATIVE FREE(60 S PACK) (QTY: 5160 PACKS) | 1 | $160.4K | 1.9% |
| 9 | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION 2% /0.5% PRESERVATIVE FREE60 S PACKQTY: 5136 PACKS | 1 | $160.0K | 1.9% |
| 10 | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION 2%/ 0.5% PRESERVATIVE FREE60 S PACKQTY: 5119 PACKS | 1 | $159.0K | 1.9% |
Showing top 10 of 299 Vati formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 74%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR handles the highest volume with 112 shipments. Transit time averages 22 days by sea.
Market Dynamics
India's vati exports to United States are driven primarily by a handful of large-scale manufacturers. EUGIA PHARMA SPECIALITIES LIMITED with 26 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 32 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — EUGIA PHARMA SPECIALITIES LIMITED, MANKIND PHARMA LIMITED, MANKIND PHARMA LTD — together account for 91% of total trade value on this route. The average shipment value of $22.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as timolol maleate ophthalmic solution usp(0.5% w/v as timolol) ( (preservative free) ) ( 60x0.3ml ) ( qty- 11820.000) and dorzolamide hydrochloride and timolol maleate ophthalmic solution 2%/0.5% preservative free(60 s pack)(qty: 5254 packs), suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, AUROBINDO PHARMA USA INC is the largest importer with 20 shipments worth $3.1M USD — representing 38% of all vati imports from India on this route. A total of 59 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $8.3M
- Avg. Shipment
- $22.3K
- Suppliers
- 32
- Buyers
- 59
- Transit (Sea)
- ~22 days
- Annual Growth
- +29.2%
Unlock the Full India to United States Vati Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 373 shipments on this route.
Frequently Asked Questions — India to United States Vati Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Vati to United States?
The leading Indian exporters of Vati to United States are EUGIA PHARMA SPECIALITIES LIMITED, MANKIND PHARMA LIMITED, MANKIND PHARMA LTD. EUGIA PHARMA SPECIALITIES LIMITED holds the largest market share at approximately 45% of total trade value on this route.
Q What is the total value of Vati exports from India to United States?
India exports Vati to United States worth approximately $8.3M USD across 373 recorded shipments. The average value per shipment is $22.3K USD.
Q Which ports does India use to ship Vati to United States?
The most active port of origin is DELHI AIR with 112 shipments. Indian exporters primarily use sea freight for this route, with 74% of shipments going by sea and 21% by air.
Q How long does shipping take from India to United States for Vati?
The average transit time for Vati shipments from India to United States is approximately 22 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to United States Vati trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 29.2% with demand growth tracking at 26.2%. The route is ranked #14 among India's top Vati export destinations globally.
Q How many suppliers are active on the India to United States Vati route?
There are currently 32 active Indian suppliers exporting Vati to United States. The market is moderately concentrated with EUGIA PHARMA SPECIALITIES LIMITED accounting for 45% of total shipment value.
Q Who are the main importers of Vati from India in United States?
The leading importers of Indian Vati in United States include AUROBINDO PHARMA USA INC, LIFESTAR PHARMA LLC, AUROLOGISTICS LLC, (AUROBINDO PHARM, NORTHSTAR DISTRIBUTION CENTER 8912,, RXCROSSROADS 3PL LLC. AUROBINDO PHARMA USA INC is the largest buyer with 20 shipments worth $3.1M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Vati.
- 2.Supplier/Buyer Matching: 32 Indian exporters and 59 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 373 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
373 Verified Shipments
32 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists